NCT01843868 2024-08-07
Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP
Australasian Leukaemia and Lymphoma Group
Phase NA Withdrawn
Clinical Trials
34 trialsNCT06451302 2024-06-11
Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study
Sun Yat-sen University
Phase NA Active not recruiting
NCT00656669 2023-05-23
Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer
Indiana University
Phase NA Completed
NCT00346125 2022-12-15
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT03908528 2021-10-11
Alpha-Lipoic Acid in Breast Cancer Patients
Damanhour University
Phase NA Completed
NCT01156883 2021-09-13
LAL1308
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Completed
NCT01446809 2020-04-13
Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
University of Washington
Phase NA Completed
NCT02786719 2020-03-12
SPRING
Baylor College of Medicine
Phase NA Completed
NCT00544219 2019-05-15
PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Swiss Cancer Institute
Phase NA Completed
NCT00895414 2019-05-08
Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT00681993 2019-01-22
PBIC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00283621 2018-11-07
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
M.D. Anderson Cancer Center
Phase NA Completed
NCT03360760 2018-08-28
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum
Peking University People's Hospital
Phase NA Unknown
NCT01489410 2017-08-31
Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma
University of Minnesota
Phase NA Withdrawn
NCT00730483 2017-08-25
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Yale University
Phase NA Terminated
NCT00343863 2017-07-11
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
University of Washington
Phase NA Completed
NCT03000036 2016-12-21
Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
University of Campinas, Brazil
Phase NA Completed
NCT00513188 2016-12-15
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
University of Miami
Phase NA Withdrawn
NCT02637375 2016-05-30
A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer
University of Chicago
Phase NA Withdrawn
NCT01857726 2016-04-28
Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion
Seoul National University Hospital
Phase NA Withdrawn
NCT01490060 2016-04-11
Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
M.D. Anderson Cancer Center
Phase NA Completed
NCT00187057 2015-08-27
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
St. Jude Children's Research Hospital
Phase NA Completed
NCT00577096 2015-04-06
Effects of Exercise in Combination With Epoetin Alfa
University of Arkansas
Phase NA Completed
NCT00673179 2014-09-10
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00651755 2013-07-02
Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients
M.D. Anderson Cancer Center
Phase NA Completed
NCT00544167 2013-04-01
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
SCRI Development Innovations, LLC
Phase NA Completed
NCT00410488 2013-03-22
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
M.D. Anderson Cancer Center
Phase NA Completed
NCT01677468 2012-09-03
Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma
Hallym University Medical Center
Phase NA Unknown
NCT00538525 2012-05-30
Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT00538395 2011-12-13
Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer
King Faisal Specialist Hospital & Research Center
Phase NA Unknown
NCT00110006 2010-06-11
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT01125020 2010-05-18
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation
Shanghai Jiao Tong University School of Medicine
Phase NA Unknown
NCT00141648 2009-10-01
Chemotherapy and Radiotherapy for Osteolymphoma
Trans Tasman Radiation Oncology Group
Phase NA Completed
NCT00187070 2008-05-07
Large Cell Lymphoma Pilot Study III
St. Jude Children's Research Hospital
Phase NA Completed